Your browser doesn't support javascript.
loading
Discovery of Quinacrine as a Potent Topo II and Hsp90 Dual-Target Inhibitor, Repurposing for Cancer Therapy.
Pan, Xin; Mao, Teng-Yu; Mai, Yan-Wen; Liang, Cheng-Cheng; Huang, Wei-Hao; Rao, Yong; Huang, Zhi-Shu; Huang, Shi-Liang.
Afiliación
  • Pan X; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
  • Mao TY; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
  • Mai YW; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
  • Liang CC; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
  • Huang WH; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
  • Rao Y; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
  • Huang ZS; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
  • Huang SL; Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Guangzhou 510120, China.
Molecules ; 27(17)2022 Aug 29.
Article en En | MEDLINE | ID: mdl-36080326
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Idioma: En Revista: Molecules Asunto de la revista: BIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Idioma: En Revista: Molecules Asunto de la revista: BIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China